BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 16621226)

  • 1. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial.
    Vigil-De Gracia P; Lasso M; Ruiz E; Vega-Malek JC; de Mena FT; López JC;
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):157-62. PubMed ID: 16621226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial.
    Vigil-De Gracia P; Ruiz E; López JC; de Jaramillo IA; Vega-Maleck JC; Pinzón J
    Hypertens Pregnancy; 2007; 26(2):163-71. PubMed ID: 17469006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy.
    Mabie WC; Gonzalez AR; Sibai BM; Amon E
    Obstet Gynecol; 1987 Sep; 70(3 Pt 1):328-33. PubMed ID: 3306494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT trial.
    Hennessy A; Thornton CE; Makris A; Ogle RF; Henderson-Smart DJ; Gillin AG; Child A
    Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):279-85. PubMed ID: 17627681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol.
    Elatrous S; Nouira S; Ouanes Besbes L; Marghli S; Boussarssar M; Sakkouhi M; Abroug F
    Intensive Care Med; 2002 Sep; 28(9):1281-6. PubMed ID: 12209278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis.
    Magee LA; Cham C; Waterman EJ; Ohlsson A; von Dadelszen P
    BMJ; 2003 Oct; 327(7421):955-60. PubMed ID: 14576246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patients.
    Gaynor MF; Wright GC; Vondracek S
    Ther Adv Cardiovasc Dis; 2018 Jan; 12(1):7-15. PubMed ID: 29265003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive drugs in pregnancy.
    Naden RP; Redman CW
    Clin Perinatol; 1985 Oct; 12(3):521-38. PubMed ID: 2865023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy of nifedipine and hydralazine in hypertensive crisis in pregnancy.
    Rezaei Z; Sharbaf FR; Pourmojieb M; Youefzadeh-Fard Y; Motevalian M; Khazaeipour Z; Esmaeili S
    Acta Med Iran; 2011; 49(11):701-6. PubMed ID: 22131238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials.
    Sridharan K; Sequeira RP
    Br J Clin Pharmacol; 2018 Sep; 84(9):1906-1916. PubMed ID: 29974489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks of parenteral antihypertensive therapy for the treatment of severe maternal hypertension are low.
    Sharma KJ; Rodriguez M; Kilpatrick SJ; Greene N; Aghajanian P
    Hypertens Pregnancy; 2016; 35(1):123-8. PubMed ID: 26910380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of intravenous labetalol and hydralazine for severe hypertension in pregnancy in Northeastern Nigeria: A randomized controlled trial.
    Muhammad S; Usman H; Dawha YM; Yahya A; Yekeen A; Bako B
    Pregnancy Hypertens; 2022 Aug; 29():1-6. PubMed ID: 35605426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does labetalol predispose to pulmonary edema in severe pregnancy-induced hypertensive disease?
    Gilson GJ; Kramer RL; Barada C; Izquierdo LA; Curet LB
    J Matern Fetal Med; 1998; 7(3):142-7. PubMed ID: 9642612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of hypertensive emergencies of pregnancy by hydralazine bolus injection vs continuous drip--a comparative study.
    Begum MR; Quadir E; Begum A; Akhter S; Rahman K
    Medscape Womens Health; 2002; 7(5):1. PubMed ID: 12466730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of efficacy of intravenous labetalol and intravenous hydralazine for management of pre-eclampsia in pregnant women.
    Kausar M; Husain S; Hussain R
    Afr Health Sci; 2023 Mar; 23(1):320-325. PubMed ID: 37545898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs in pregnancy. Antihypertensives.
    Magee LA
    Best Pract Res Clin Obstet Gynaecol; 2001 Dec; 15(6):827-45. PubMed ID: 11800527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor analysis, including antihypertensive medication, of the outcome of pregnancy in pregnancy-associated hypertension.
    Hussein M; Mooij JM; Roujouleh H
    Kidney Blood Press Res; 2001; 24(2):124-8. PubMed ID: 11435745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial.
    Raheem IA; Saaid R; Omar SZ; Tan PC
    BJOG; 2012 Jan; 119(1):78-85. PubMed ID: 21985500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute pregnancy-related hypertension: labetalol and hydralazine compared.
    Walker JJ; Greer I; Calder AA
    Postgrad Med J; 1983; 59 Suppl 3():168-70. PubMed ID: 6647203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnesium sulphate therapy in women with pre-eclampsia and eclampsia in Kuwait.
    Omu AE; Al-Harmi J; Vedi HL; Mlechkova L; Sayed AF; Al-Ragum NS
    Med Princ Pract; 2008; 17(3):227-32. PubMed ID: 18408392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.